InvestorsHub Logo
Followers 1
Posts 114
Boards Moderated 0
Alias Born 12/26/2017

Re: KeithamdMIC post# 27921

Tuesday, 07/30/2019 8:34:44 AM

Tuesday, July 30, 2019 8:34:44 AM

Post# of 34624
Ultimately, the decision will be made by the FDA. Question is what they will require to approve Multi-TAA. Usually, a prospective randomized trial is necessary, comparing the new drug too SOC. However, to run such a trial ethically, you must have equipoise, that is you can't know with certainty which treatment is better. I would assert that if we see another CR or even two in group A, it would prove Multi-TAA is synergistic with chemo, since CRs are so rare with chemo alone. Would the FDA accept this evidence. I don't know. They could grant accelerated approval and then follow more patients to be sure the CR rate holds up and that translates to OS.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News